USE OF CATIONIC LIPOSOMES COMPRISING PACLITAXEL

(19)

(11)

EP 2 286 794 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	01.06.2016 Bulletin 2016/22

(45)	Mention of the grant of the patent:
	30.03.2016 Bulletin 2016/13

(21)	Application number: 10180750.1

(22)	Date of filing: 15.10.2004

(51)

International Patent Classification (IPC):

A61K 9/127^(2006.01)
A61P 35/00^(2006.01)

A61K 31/335^(2006.01)
A61K 31/00^(2006.01)

(54)	USE OF CATIONIC LIPOSOMES COMPRISING PACLITAXEL VERWENDUNG VON KATIONISCHEN LIPOSOMEN MIT PACLITACEL UTILISATION DE LIPOSOMES CATIONIQUES AVEC PACLITAXEL

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30)

Priority:

15.10.2003 EP 03023539
09.01.2004 EP 04000361

(43)	Date of publication of application:
	23.02.2011 Bulletin 2011/08

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	04790494.1 / 1673069

(73)	Proprietor: SynCore Biotechnology CO., LTD
	Tung Shan Shine, I-Lan (TW)

(72)	Inventors:
	Teifel, Michael 64331, Weiterstadt (DE) Michaelis, Uwe 82362, Weilheim (DE) Sauer, Birgitta 82166, Gräfelfing (DE) Bartelheim, Kerstin 82269, Walleshausen (DE) Brunner, Christoph 82387 Antdorf (DE)

(74)	Representative: Weickmann & Weickmann PartmbB
	Postfach 860 820 81635 München 81635 München (DE)

(56)

References cited: :

WO-A-01/17508
WO-A-2004/002455
US-A- 6 090 955

WO-A-98/40052
WO-A-2004/002468

CAMPBELL R B ET AL: "INFLUENCE OF CATIONIC LIPIDS ON THE STABILITY AND MEMBRANE PROPERTIES OF PACLITAXEL-CONTAINING LIPOSOMES" JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION. WASHINGTON, US, vol. 90, no. 8, August 2001 (2001-08), pages 1091-1105, XP001101828 ISSN: 0022-3549
EMERSON D L: "Liposomal delivery of camptothecins" PHARMACEUTICAL SCIENCE AND TECHNOLOGY TODAY, ELSEVIER TRENDS JOURNALS, CAMBRIDGE,, GB, vol. 3, no. 6, 1 June 2000 (2000-06-01), pages 205-209, XP002235822 ISSN: 1461-5347


	Remarks:
	The file contains technical information submitted after the application was filed and not included in this specification

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).